Skip to main content

Table 3 Associations between intake of AMY1 copy number and CVD and mortality risk (n = 3932)

From: Starch intake, amylase gene copy number variation, plasma proteins, and risk of cardiovascular disease and mortality

 

AMY1 copy number

P trend

Continuousa

P value

1–4 copies

5–6 copies

7–9 copies

10 and above copies

CVD

 Cases/non-case

166/668

303/1189

186/788

121/511

-

  

 Age- and sex-adjusted model

1 [reference]

1.03 (0.86, 1.25)

0.98 (0.79, 1.20)

0.99 (0.78, 1.25)

0.75

1.02 (0.99, 1.05)

0.27

CHD

 Cases/non-case

90/744

173/1319

99/875

72/560

-

  

 Age- and sex-adjusted model

1 [reference]

1.10 (0.85, 1.42)

0.96 (0.72, 1.27)

1.09 (0.80, 1.48)

0.95

1.03 (0.99, 1.07)

0.17

Ischemic stroke

 Cases/non-case

78/756

127/1365

82/892

49/583

-

  

 Age- and sex-adjusted model

1 [reference]

0.93 (0.70, 1.23)

0.92 (0.67, 1.25)

0.83 (0.58, 1.19)

0.33

1.01 (0.96, 1.06)

0.76

All-cause mortality

 Cases/non-case

302/532

547/945

361/613

223/409

   

 Age- and sex-adjusted model

1 [reference]

1.03 (0.90, 1.19)

1.04 (0.89, 1.21)

0.96 (0.81, 1.15)

0.77

1.01 (0.99, 1.03)

0.49

CVD mortality

 Cases/non-case

91/743

173/1319

99/875

58/574

   

 Age- and sex-adjusted model

1 [reference]

1.08 (0.84, 1.39)

0.94 (0.71, 1.25)

0.83 (0.60, 1.15)

0.16

1.02 (0.98, 1.06)

0.44

  1. Obtained by using a multivariable logistic regression model
  2. aHazard ratio for per increase of 1 AMY1 copy number